BIOMERICA INC (BMRA) Stock Price

BMRAStock

$2.14−32.28%52W

Market Cap$6.61M

P/E—

PEG Ratio—

Div yield—

Beta0.44

BMRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-10.03%

Price vs S&P 500 (4W)38.33%

VGM Score51.05

Book Value / Share (Quarterly)$1.09

P/TBV (Annual)2.23x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-34.47%

Cash Flow / Share (Quarterly)$-1.05

Price vs S&P 500 (YTD)-27.90%

Gross Margin (TTM)4.32%

Net Profit Margin (TTM)-96.49%

EPS (TTM)$-1.59

10-Day Avg Trading Volume0.35M

EPS Excl Extra (TTM)$-1.59

Revenue Growth (5Y)-4.51%

EPS (Annual)$-2.16

ROI (Annual)-121.14%

Gross Margin (Annual)9.38%

Net Profit Margin (5Y Avg)-93.05%

Cash / Share (Quarterly)$0.44

Revenue Growth QoQ (YoY)-11.80%

ROA (Last FY)-83.65%

Revenue Growth TTM (YoY)-23.81%

EBITD / Share (TTM)$-1.96

ROE (5Y Avg)-81.57%

Operating Margin (TTM)-123.74%

Cash Flow / Share (Annual)$-1.52

P/B Ratio1.54x

P/B Ratio (Quarterly)1.85x

Net Income / Employee (Annual)$-93,800

EV / Revenue (TTM)0.87x

Net Interest Coverage (TTM)83.00x

ROA (TTM)-70.41%

EV / EBITDA (TTM)14.50x

EPS Incl Extra (Annual)$-2.16

Current Ratio (Annual)2.80x

Quick Ratio (Quarterly)1.46x

3-Month Avg Trading Volume0.05M

52-Week Price Return-32.28%

Revenue / Employee (TTM)$81,600

Tangible BV / Share (Quarterly)$1.02

P/S Ratio (Annual)0.96x

Asset Turnover (Annual)0.89x

52-Week High$3.24

Operating Margin (5Y Avg)-95.54%

EPS Excl Extra (Annual)$-2.16

CapEx CAGR (5Y)-20.97%

Tangible BV CAGR (5Y)-22.69%

26-Week Price Return1.90%

Quick Ratio (Annual)1.80x

13-Week Price Return-11.93%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.64x

Enterprise Value$3.77M

Revenue / Share Growth (5Y)28.58%

Asset Turnover (TTM)0.73x

Book Value / Share Growth (5Y)5.90%

Revenue / Employee (Annual)$100,200

Inventory Turnover (Annual)2.49x

Pretax Margin (Annual)-93.62%

Cash / Share (Annual)$0.94

3-Month Return Std Dev67.76%

Gross Margin (5Y Avg)10.00%

Net Income / Employee (TTM)$-78,800

ROE (Last FY)-121.14%

Net Interest Coverage (Annual)-216.33x

EPS Basic Excl Extra (Annual)$-2.16

P/FCF (TTM)1.41x

Receivables Turnover (TTM)3.92x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.59

Receivables Turnover (Annual)6.33x

ROI (TTM)-98.14%

P/S Ratio (TTM)1.18x

Pretax Margin (5Y Avg)-92.62%

Revenue / Share (Annual)$2.31

Tangible BV / Share (Annual)$1.52

Price vs S&P 500 (52W)-50.84%

Year-to-Date Return-15.08%

5-Day Price Return27.38%

EPS Normalized (Annual)$-2.16

ROA (5Y Avg)-60.11%

Net Profit Margin (Annual)-93.64%

Month-to-Date Return43.62%

Cash Flow / Share (TTM)$-0.41

EBITD / Share (Annual)$-2.20

Operating Margin (Annual)-96.72%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-81.57%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.59

P/TBV (Quarterly)1.99x

P/B Ratio (Annual)2.10x

Inventory Turnover (TTM)2.51x

Pretax Margin (TTM)-96.00%

Book Value / Share (Annual)$1.61

Price vs S&P 500 (13W)-13.89%

Beta0.44x

P/FCF (Annual)4.52x

Revenue / Share (TTM)$1.44

ROE (TTM)-98.14%

52-Week Low$1.45

vGradeB

gGradeD

mGradeC

vgmGradeC

BMRA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2023	Apr 14, 2023	—	-$0.96	—

BMRA Analyst Recommendations

Apr 2022

May 2022

Jun 2022

Jul 2022

4.29

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
BMRABIOMERICA INC	B	D	C	$2.14
IDXXIdexx Laboratories Inc	D	B	C	$554.99
LNTHLantheus Holdings, Inc	C	B	B	$100.77
CLDXCelldex Therapeutics, Inc	F	F	B	$39.12
NEOGNeogen Corp	C	C	B	$11.66
NTLAIntellia Therapeutics, Inc	D	D	C	$12.87
QDELQuidelOrtho Corporation Common Stock	C	C	C	$14.74
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.10
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	$7.12
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.67
MYGNMyriad Genetics Inc	B	C	D	$3.16
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.13
ICCCImmucell Corp	C	B	B	$9.94
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.35
TRIBTrinity Biotech plc	B	D	F	$9.68
VNRXVolitionRx Limited	B	A	F	$0.45
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	D	$1.85
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	$2.82
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	B	$0.02

About BIOMERICA INC

Biomerica develops and markets medical diagnostic products for early detection and monitoring of chronic diseases, with a focus on gastrointestinal conditions, food intolerances, and diabetes. The company generates the majority of its revenue from Asia while maintaining a global presence across Europe, North America, the Middle East, and South America.